triticum aestivum pollen
Allergenexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Jul 14, 2022 (NCT06501248)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSF1KAH8374D ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06496100 | Phase 3 | Jan 3, 2024 | Government of Mexico, Instituto Mexicano del Seguro Social |
| NCT06950138 | Phase 3 | Jan 3, 2023 | Government of Mexico |
| NCT06501248 | Phase 3 | Jul 14, 2022 | Government of Mexico, Instituto Mexicano del Seguro Social |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Mexico | Government | 3 | 3 | 1 | 2022 |
| Instituto Mexicano del Seguro Social | Government | 2 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1